Pacira Pharmaceuticals Debt to Equity Ratio:0.3825 for Dec. 31, 2012
Pacira Pharmaceuticals Debt to Equity Ratio Chart
Pacira Pharmaceuticals Historical Debt to Equity Ratio DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||0.3825|
|Sept. 30, 2012||0.3099|
|June 30, 2012||0.261|
|March 31, 2012||0.6712|
|Dec. 31, 2011||0.5299|
|Sept. 30, 2011||1.836|
|June 30, 2011||1.100|
|March 31, 2011||0.8071|
About Debt to Equity Ratio
Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.
A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.
It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
PCRX Debt to Equity Ratio Benchmarks
PCRX Debt to Equity Ratio Rankings
2717 of 8002
385 of 684 in Healthcare
30 of 54 in Drug Manufacturers - Major
PCRX Debt to Equity Ratio Range, Past 5 Years
Zacks May 10
Seeking Alpha May 8